2005: Caravel Group is launched to fill the void left by big medical communications and marketing consultancies: a truly strategic and innovative partner.
115%: Attendance increase of high-value target physicians to a novel dinner program series for a client targeting hematologists and oncologists.
2008: John Halsey and Renie Dornbusch join Caravel Group, bringing with them years of experience in serving life sciences companies, and taking Caravel's capabilities to new levels.
370%: Increase in number of correct customer records as part of data discovery, authentification, and validation project for a Top 5 biotech client.
As a strategic partner, our core philosophy is to bring innovations to customer insight, build client capabilities to establish and sustain market leadership, provide practical recommendations, and build an enduring partnership based on trust and respect. We strive to consistently exceed expectations and dedicate ourselves to exceptional client service. Named after the nimble and highly reliable ships explorers used to navigate uncharted waters and explore new lands, Caravel Group is dedicated to being strategic, innovative, and effective.
Caravel Group brings a unique set of principles to each partnership. We strive to become an extension of your team, a true strategic partner whom you can trust to look out for your best interests - not only solving immediate needs, but keeping your long-term strategic business goals in mind.
Murat "Murry" Alper
Practice Lead, Market Leadership
Murat Alper founded Caravel Group in 2005 after 10 years in biopharmaceutical marketing and sales. Murat is responsible for the incorporation and integration of strategic marketing fundamentals in all of the services Caravel Group provides to its clients. Before Caravel Group, Murat held various marketing and sales positions at Genentech and Bristol-Myers Squib, with experience in specialty and primary care markets
Director, Client Services and Operations
Renie Dornbusch joined Caravel Group in 2008 to expand operational capabilities and elevate client services through innovative approaches to exceeding clients' business goals. Renie brings more than 15 years of hospitality and health care industry experience, with previous positions at Omnicom Group's Health Science Communications division, AmerisourceBergen's NMCR division, and Marriott Hotels
Keith Engelke, PhD, MBA, joined Caravel Group in 2006 and is responsible for providing strategic oversight for the medical/clinical component of the group's solutions. Prior to joining the Caravel Group, Keith held numerous positions in medical affairs, product development, and marketing with Astra Merck, AstraZeneca, and Cardinal Health. He received his PhD in Basic Medical Sciences from the University of Florida, completed post-doctoral training at the Mayo Clinic in Rochester, MN, and has published numerous peer-reviewed papers and more than 30 abstracts.Email Me
Caravel Group is based in San Francisco, and draws energy and inspiration from this booming hub of life sciences and biotech, where thought leaders from technology, top academic institutions, and venture capital meet, and where the culture encourages and rewards innovation.